This site is intended for healthcare professionals
News

CSL Behring to acquire global license rights to adeno-associated virus gene therapy program, AMT 061 for hemophilia B from uniQure.

Read time: 1 mins
Last updated:29th Jun 2020
Published:28th Jun 2020
Condition: Haemophilia B
Type: drug
Register free for full access to medthority.com